Summary: Genetic polymorphisms in xenobiotic transporters have recently been claried to be associ ated with change in drug distribution and disposition. To expand on recent identication of direct interaction and functional regulation of several transporters by a PDZ (PSD95, Dlg and ZO1) domain containing protein PDZK1, the eect of mutation in PDZK1 on transport activity and subcellular localiza tion of organic cation W carnitine transporters OCTN1 and OCTN2, and oligopeptide transporter PEPT2 was examined in the present study. HEK293 cells stably expressing a mutant transcript PDZK1E195K (HEK293 W PDZK1E195K) were constructed, followed by transient transfection of cDNA for each trans porter. Uptake of tetraethylammonium by OCTN1 was much higher in HEK293 W PDZK1 cells, com pared with that in the parent HEK293 cells, the uptake in HEK293 W PDZK1E195K cells showing middle range between the two values. Such dierence in transport activity was accounted for the dierence in transport capacity, with minimal change in anity of OCTN1 to the substrate or other compounds. The similar dierence among HEK293 W PDZK1, HEK293 W PDZK1E195K and HEK293 cells was also observed in transport property of OCTN2 and PEPT2, whereas the dierence was not so remarkable in each transporter with the last four amino acids deleted, that has much lower interaction potential with PDZK1. Immunohistochemical analysis indicated that OCTN1 was colocalized with PDZK1 on cell surface, whereas colocalization with PDZK1E195K was partially observed in cytoplasmic region. These results suggest a novel hypothesis that mutation in PDZK1 potentially changes transport property of various types of xenobiotic transporters by aecting their subcellular localization, possibly leading to change in disposition of various types of substrate drugs.
Introduction
Recent molecular biological researches have specied PDZ (PSD95, Dlg and ZO1) domain containing pro teins which may play a role as scaolds for transmem brane proteins such as transporters, thereby aecting subcellular localization, transporting activity and W or cellsurface stability of, at least, certain types of xenobiotic transporters including organic cation W carnitine transporters OCTN1 and OCTN2, oligopep tide transporter PEPT2, urateanion exchanger URAT1, organic anion transporter OAT4 and organic anion transporting polypeptide (Oatp) 1a1. 16 ) PDZ domains generally consist of 8090 amino acids, and can recognize internal and W or extreme Cterminal pep tide sequences (PDZ binding motif) usually composed of 3 to 8 amino acids. 7) PDZ domain containing proteins are considered to play important roles in the targeting of proteins to specic cell membranes, as well as assem bling proteins for ecient signal transduction. 8, 9) Our recent screening using yeast twohybrid revealed physi cal interaction between the PDZ proteins and several xenobiotic transporters including OCTN, PEPT, OAT and OATP family members, almost all of which have class I PDZ domain interacting motif at their Ctermi nus (S W TXF, F is a hydrophobic amino acid). 3) In terestingly, most of such transporters interacting with PDZ proteins are expressed on apical membranes of epithelial cells in the kidney and small intestine, im plying possible importance of the protein interaction in subcellular localization of xenobiotic transporters. 3, 10) Among the PDZ proteins interacting with the trans porters, regulatory function of PDZK1 has been best characterized. PDZK1 was rst identied as a protein that is upregulated in rats on a lowphosphate diet 11) or in several carcinoma cell lines. 12) PDZK1 has four PDZ domains in its structure. In in vitro studies, PDZK1 has been demonstrated to increase substrate transporting activity of URAT1, OCTN2 and OAT4 by dierent mechanisms, ie., increase in cellsurface expression of URAT1 and OAT4, and direct regulation without obvious change in cellsurface expression of OCTN2. 2, 4, 5) Transport activity of PEPT2 was also slightly increased in the presence of PDZK1.
3) Wang et al. 6) have recently claried downregulation of Oatp1a1 in hepatocytes of pdzk1 (| W |) mouse, demon strating fundamental role of PDZK1 in cellsurface expression of the transporter.
It might be noteworthy that PDZK1 can thus bind to various types of xenobiotic transporters and may aect their transport properties, leading to a novel hypothesis that genetic variation in PDZK1 may aect function and W or cellsurface expression of those transporters, thereby aecting membrane transport of many types of substrate drugs. Therefore, it appears important to clarify whether the genetic variation of PDZK1 aects the property of interacting transporters. Understanding of the potential eect of genetic variation in transport ers and their regulators on drug disposition may help development of personalized medicine. However, up to now, no information has been available on how the mutation in PDZK1 aects transport properties of the interacting transporters.
In the present study we attempted to examine the eect of a mutation in PDZK1 on its regulatory eect on several xenobiotic transporters including OCTN1, OCTN2 and PEPT2.
Materials and Methods
Materials: Rabbit polyclonal antibody for OCTN1 was raised as described previously. 13 4) The cDNA encoding OCTN1, OCTN2 and PEPT2 was then transiently transfected according to the calcium phosphate precipitation method, and, at 48 hr after transfection, cells were harvested and suspended in a transport medium (125 mM NaCl, 4.8 mM KCl, 5.6 mM Dglucose, 1.2 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO4, and 25 mM HEPES, pH 7.4). Uptake experiment was then performed by the siliconoil layer method as described previously. 4) Because we compared transport activity between three cell lines (HEK293, HEK293 W PDZK1 and HEK293 W PDZK1E195K) in the present study, we routinely observed uorescence intensity in each cell line by uorescence microscope (Axiovert S100; Carl Zeiss, Jena, Germany) after transient transfection of YFP (as a cytosolic protein) or a chimeric protein YFPOCTN2 (as a membranous protein) with an aim to check transfection eciency. There was no clear dierence in the uorescence among each cell line.
Immunocytochemical analysis: HEK293 cells were grown on cover glass (15~15 mm; thickness, 0.120.17 mm; micro cover glass, Matsunami Glass Inc., Osaka, Japan) and transiently transfected with cDNA encoding each transporter as described above. At 48 hr after the transfection, cells were xed with 3z formaldehyde in phosphatebuered saline (PBS), permeabilized with methanol for 5 min, and incubated with PBS containing 3z blocking agent (Amersham Biosciences) for 30 min at room temperature. Cells were then incubated with antihuman OCTN1 and anticmyc antibodies for 1 hr at room temperature at a dilution of 1:20 and 1:100, respectively, washed with PBS, and then incubated with Alexa Fluor 488 goat antirabbit IgG and Alexa Fluor 594 goat antimouse IgG (Molecular Probes Inc., Eugene, OR) at a dilution of 1:200 in PBS containing 3z Blocking Agent. Attached cells were sealed onto the slides using Vectrashield mounting medium with 4?,6 dianidino2phenylindole (Vector Laboratories, Burlin game, CA) and examined under a confocal laser scan ning uorescence microscope (LSM 510; Carl Zeiss).
Western blot analysis: At 48 hr after the transfec tion of OCTN1, the cells were washed twice with PBS, harvested and solubilized in RIPAY buer containing 1z NONIDET P40, 75 mM NaCl, 50 mM TrisHCl (pH 7.5) and protease inhibitors. Westernblotting was then performed using antiOCTN1, anticmyc and anti gadaptin antibodies as described previously.
4)
Yeast twohybrid analysis: Yeast twohybrid analysis was performed as described previously. 3) Briey, yeast cells were cotransformed with pGBKT7(TRP) encoding GAL4bd fused to the Ctermi nus of each transporter, and pGADT7(LEU2) vector encoding GAL4ad fused to wildtype and mutant PDZK1 construct. Cotransformed cells were further cultured on plates lacking leucine and tryptophan, with or without histidine.
Plate assays: Glutathione Stransferase (GST) fusion proteins and His 6 tagged PDZK1 were obtained from E. coli (BL21 strain) transformed with pGEX6P 1 and pET30 constructs, respectively, according to the manufacturer's instructions. The protein content of each His6tagged and GSTfusion proteins was deter mined both by CBBstaining after SDSPAGE and Bradford method with a protein assay kit (BioRad, Hercules, CA), in both of which bovine serum albumin were used as a standard. HisSelect HS NickelCoated 96well plate (Sigma) was rst coated with 0.02 mM of His 6 tagged PDZK1 dissolved in PBS with 1z BSA for 4 hr at 49 C. After washing the plate twice with PBS containing 0.1z Tween20, GST Cterminus fusion proteins dissolved in PBS with 0.05z Triton X100 was added and incubated at 49 C for 2 hr. After three washings, the plate was incubated at room temperature for 1 hr with HRP conjugated antiGST antibody (Amersham Biosciencces), followed by threetimes washings. Reaction mixture (TMB peroxydase substrate kit, BioRad) was added, and absorption at 655 nm was then monitored.
Results
Eect of PDZK1E195K on transport property of OCTN1, OCTN2 and PEPT2: PDZK1 with NCBI reference sequence (accession# NMä002614) was used as a wildtype in the present study. This PDZK1 has the same amino acid sequence with that in other PDZK1 clones (accession# BC006518 and BC006496) reported in NCBI database. On the other hand, PDZK1 (acces sion# AF012281) originally isolated by Kocher et al. 12) has a dierence in the sequence (PDZK1681GÀA, encoding E195K). Because this PDZK1E195K clone was isolated from normal human kidney cDNA libra ry, 12) this clone should also be present in human ge nomes. E195K is located in the second PDZ domain of PDZK1. According to crystal structure, 14) PDZ domain is formed from sixstranded antiparallel bbarrels capped by two ahelices, and E195K is presumed to be located in the second ahelix that could be important to interact with Cterminus of membrane proteins. Since the second PDZ domain in PDZK1 has been proposed to be involved in interaction with Cterminus of various transporters including OCTN1, OCTN2 and PEPT2, 3, 4) we then attempted to clarify whether such dierence in amino acid sequence aects regulatory eect of PDZK1 on these three transporters in the present study. Although Kocher et al. 12, 15) have reported interaction of PDZK1E195K with the Cterminus of multidrug resistance associated protein 2 and another associated protein MAP17, no information is available on its interaction with other transporters. In addition, up to now, there is no information on regulatory function and association with any diseases of PDZK1E195K.
To examine the eect of mutant PDZK1 on activity of these transporters, we obtained HEK293 (Fig. 1A , C and E), whereas such uptake was relatively small in HEK293 cells transfected with vector alone (Fig. 1B, D and F) . All of these uptakes were higher in HEK293 W PDZK1 cells, com pared with those in HEK293 cells (Fig. 1A, C (Fig. 1C) . On the other hand, the dier ence in the uptake by OCTN1 and PEPT2 between HEK293 W PDZK1 and HEK293 W PDZK1E195K cells was not so obvious in the initial phase, but more obvious at longer time periods (Fig. 1A and E) . Student ttest was performed for the uptake by each transporter between HEK293 W PDZK1 and HEK293 cells, and that between HEK293 W PDZK1E195 and HEK293 cells. All the uptake values for OCTN1, OCTN2 and PEPT2 were signicantly higher in HEK293 W PDZK1 or HEK293 W PDZK1E195K cells than those in HEK293 cells (pº0.05).
To examine specicity of the stimulatory eect of PDZK1 and PDZK1E195K, each cell line was tran siently transfected with OCTN1D4, OCTN2D4 and PEPT2D4, these lacking a PDZ binding motif consist ing of 4 amino acids at their extreme Cterminus, since interaction potential of these constructs with PDZK1 was almost abolished. 3, 4) The stimulatory eect of 
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PDZK1 and PDZK1E195K was not so obvious on uptake of each substrate by OCTN1D4, OCTN2D4 and PEPT2D4 (Fig. 1B, D and F (Fig. 2) . Thus, the dierence in Km and Vmax values for initial uptake of TEA by OCTN1 was not so obvious between HEK293 W PDZK1 and HEK293 W PDZK1E195K cells.
To further characterize the stimulatory eect of PDZK1 and PDZK1E195K, we next compared inhibitory eect of pyrilamine and verapamil, both being substrates of OCTN1, 16) on OCTN1mediate uptake of TEA between HEK293, HEK293 W PDZK1 and HEK293 W PDZK1E195K cells (Fig. 3) . Both compounds inhibited the TEA uptake in a concentra tion dependent manner, showing almost comparable inhibition prole between each cell line (Fig. 3) , suggest ing that substrate recognition specicity of OCTN1 was minimally aected by PDZK1 or PDZK1E195K.
Eect of PDZK1 and PDZK1E195K on subcellular localization and expression of OCTN1: To investigate possible reasons for the present nding that stimulatory eect on transport activity of OCTN1 of PDZK1E195K was weaker than that of wildtype PDZK1 (Figs. 1, 2) , subcellular localization of OCTN1 and its possible colocalization with PDZK1 were further examined by immunohistochemical analysis (Fig. 4) . In HEK293 W PDZK1 cells, OCTN1 was colocalized with PDZK1, and such colocalization was observed on cellsurface (Fig. 4A, B and C) . In HEK293 W PDZK1E195K cells, on the other hand, OCTN1 was colocalized with the HEK293 W PDZK1 (A, B, C) and HEK293 W PDZK1E195K (D, E, F) cells were transiently transfected with OCTN1, and subcellular localization of OCTN1 and PDZK1 was then immunocytochemically analyzed with an antihuman OCTN1 (A, D) and anticmyc (B, E) antibodies. Overlay image (C, F) showed that both OCTN1 and PDZK1 are colocalized, but such colocalization was observed in dierent subcellular compartments between PDZK1 and PDZK1E195K. In panels G, H and I, OCTN1 (green) and Na { W K { ATPase (red) were double stained in HEK293 W PDZK1, HEK293 W PDZK1E195K and HEK293 cells, respectively, after transient transfection with OCTN1. Arrowheads indicated cytoplasmic localization of OCTN1.
PDZK1 mutant, but both proteins were partially localized in cytoplasmic regions (Fig. 4D, E and F) . Thus, mutation in PDZK1 may aect subcellular localization of PDZK1 itself, thereby causing the change in localization of OCTN1. To further character ize the localization of OCTN1, colocalization with Na { W K { ATPase, a plasma membrane marker, was then examined. In HEK293 W PDZK1 cells, OCTN1 was HEK293 W PDZK1 and HEK293 W PDZK1E195K cells were transient ly transfected with OCTN1, followed by Western blot analysis for cel lular lysates. Band intensity assessed by a densitometric analysis was normalized to that in HEK293 W PDZK1 cells, and shown. In panel A, yeast cells were cotransformed with plasmids encoding PDZK1 or its mutants (subcloned as a fusion protein with GAL4AD into pGADT7 vector) and the Cterminus of each transporter (sub cloned as a fusion protein with GAL4BD in pGBKT7 vector). P53 was used in the control experiment. Interaction was indicated by growth on agar plates made with medium without histidine (His).
In panel B, nickelcoated 96well plate coated with His 6 tagged PDZK1 (black bars), PDZK1E195K (grey bars) and PDZK1H193A (white bars) was incubated with GSTCterminus fusion proteins for 2 hr. After washings, the plate was further incubated with HRP conju gated antiGST antibody, followed by the detection of the antibody with TMB peroxydase substrate kit. Data were normalized by the absorbance obtained for His 6 tagged PDZK1.
expressed on plasma membranes, colocalizing with Na { W K { ATPase (Fig. 4G) , whereas, in HEK293 W PDZK1E195K cells, a part of OCTN1 was not colocal ized with Na { W K { ATPase, and again found in cytoplasmic region (Fig. 4H) . Such intracellular locali zation of OCTN1 was also observed in HEK293 cells (Fig. 4I) .
To compare expression level of PDZK1, Western blot analysis was then performed for cellular lysates. Expres sion of OCTN1 was much higher in HEK293 W PDZK1 cells than HEK293 W PDZK1E195 cells, whereas almost comparable expression of PDZK1 was observed between each cell line (Fig. 5) . Expression of an en dogenous protein gadaptin was also examined in a control experiment, showing comparable level (Fig. 5) .
Physical interaction between PDZK1E195K and Cterminus of the transporters: To assess the eect of E195K mutation in PDZK1 on its interaction potential with the Cterminus of each transporter, we examined their direct interaction by two methods, yeast two hybrid analysis (Fig. 6A ) and plate assay (Fig. 6B) . Obvious dierence in interaction potential with the Cterminus of OCTN1, OCTN2 and PEPT2 was not observed between PDZK1 and PDZK1E195K, although the interaction of PDZK1E195K with the Cterminus of OCTN1 was slightly lower in both experiments than that of wildtype PDZK1 (Fig. 6) .
Another PDZK1 mutant PDZK1H193A was also constructed by replacement of a histidine residue that is located in the second ahelix of the PDZ domain and involved in hydrogen bond with hydroxy group of serine or threonine residue in PDZ domain interacting motif, with alanine.
14) The interaction of PDZK1H193A with the Cterminus of OCTN1 was slightly lower in both experiments than that of wildtype PDZK1, but there was no obvious dierence from wildtype PDZK1 in interaction potential of PDZK1H193A (Fig. 6 ).
Discussion
OCTN1, OCTN2 and PEPT2 are localized on apical membranes of renal proximal tubules. Both OCTN1 and OCTN2 accept carnitine and various organic cations as substrates, whereas PEPT2 transports di and tripeptides as well as various types of therapeutic agents including blactam antibiotics.
1621) Genetic deciency in octn2 gene hinders renal reabsorption of carnitine and secretion of tetraethylammonium (TEA) in mice, sug gesting that OCTN2 plays an important role in the renal handling of its substrates. 22, 23) Essential role of renal reabsorption of peptidic compounds has recently been demonstrated in pept2
(| W |) mice. 24) Although the phar macokinetic roles of OCTN1 has not yet been demon strated in vivo, recent studies revealed the association of the risk for Crohn's disease or rheumatoid arthritis with OCTN1 single polymorphism nucleotide (SNPs). 25, 26) Thus, these three transporters could play a major role in drug disposition or pathophysiological status, leading to necessity of the present studies regarding potential eect of the mutation in their adaptor protein PDZK1 on activity of each transporter. In the present study, we demonstrated that stimulatory eect of PDZK1 on uptake of substrates by OCTN1, OCTN2 and PEPT2 especially at longer time periods was decreased by mutational change in PDZK1, whereas such eect was not so obvious on the uptake by OCTN1D4, OCTN2D4 and PEPT2D4 (Fig. 1) , suggesting that mutational change in PDZK1 may aect transport properties of various transporters. Considering the wide spectrum in substrate recognition specicity of these transporters, such mutation in PDZK1 may change membrane transport of numerous substrate drugs of the transport ers. Although the present studies were restricted only to the in vitro ones, the present ndings have proposed a novel hypothesis that genetic variation in such adaptor proteins may change membrane transport of various substrates of various transporters that directly interact with the adaptors.
Our previous studies have suggested that PDZK1 is a functional regulator of OCTN2 and PEPT2, 3, 4) whereas eect of PDZK1 on OCTN1 has not yet been reported. In the present study, we rst identied similar stimulato ry eect of PDZK1 on OCTN1mediated transport (Fig. 1A) . The stimulatory eect of PDZK1E195K on substrate uptake at longer time periods by OCTN1, OCTN2 and PEPT2 was weaker than that of wildtype PDZK1 (Fig. 1A, C and E) . Thus, eect of the E195K mutation on the stimulatory activity of PDZK1 was observed for various transporters. However, it should be noted that eect of the mutation in PDZK1 on initial phase (¿5 min) of TEA uptake by OCTN1 was not so remarkable (Fig. 1A, Fig. 2 ), whereas that on the uptake at 30 min was more obvious (Fig. 1A) . Thus, the change by the PDZK1 mutation is more evident at steadystate than initial phase, implying that there may be dierent molecular mechanisms in stimulatory eect of PDZK1 on OCTN1mediated uptake.
To understand how the mutation in PDZK1 aects its regulatory activity, subcellular localization of OCTN1 was then analyzed (Fig. 4) . Immunocytochemical analysis revealed that OCTN1 was colocalized with PDZK1 and PDZK1E195K, although OCTN1 and PDZK1E195K were partially localized in intracellular compartments (Fig. 4) . Thus, mutation of PDZK1 may aect subcellular localization of PDZK1 itself, thereby causing the change in localization and activity of transporters that interact with PDZK1. This may explain the present nding that the E195K mutation aects regulatory activity of PDZK1 for various trans porters (Fig. 1) . The partial localization of OCTN1 in intracellular compartments of HEK293 W PDZK1E195K was compatible with the lower OCTN1mediated TEA uptake especially at steadystate in HEK293 W PDZK1E195K, compared with HEK293 W PDZK1 cells (Fig. 1A ). In addition, expression level of OCTN1 in HEK293 W PDZK1E195K was also lower than that in HEK293 W PDZK1 cells (Fig. 5) , and this can also explain the dierence in TEA transport (Fig. 1A) . Although the exact molecular mechanism(s) for the decreased expression of OCTN1 was currently unknown, one of the hypotheses may include that such intracellular OCTN1 could be unstable, compared with that on cellsurface, presumably due to the intracellular degradation. It was reported that PDZK1 stabilizes URAT1 expression on cellsurface, 2) and similar stabili zation by PDZK1 may occur for OCTN1. However, expression of OCTN1 was assessed in whole cell lysates in the present study (Fig. 5) . Further studies are needed to quantitatively determine OCTN1 level on cellsurface of each cell line.
To date, it has been demonstrated that deciency of pdzk1 gene leads to decrease in the expression level of scavenger receptor BI 27) and translocation of Oatp1a1 to intracellular compartments 6) in liver. Therefore, PDZK1 could play critical roles in expression or subcellular localization of several membrane proteins including OCTN1. On the other hand, deciency of pdzk1 gene in mice causes hypercholesterolemia, due to the loss in expression of the scavenger receptor. 27) Mutaions in OCTN2 are associated with primary systemic carnitine deciency, 23) whereas more recent studies have suggest ed the association of the risk for Crohn disease 25) or rheumatoid arthritis 26) with OCTN1 SNPs, which means variation of transporters may aect not only phar macokinetics but also several diseases. Considering these ndings, several diseases might be attributed to mutations and W or SNPs in PDZK1, that change the expression, localizatoin and W or activity of transporters that interact with PDZK1.
According to sequence comparison of class I PDZ domains, 14, 28) the position of E195K is located in a2 helix within second PDZ domain in PDZK1 that is involved in binding to Cterminus of several membrane proteins. The E195Kmutation causes electric change and then may vary structure of the hydrophobic pocket in the PDZ domain, altering its interaction potential to other proteins. However, it is noted that PDZK1E195K exhibits almost comparable interaction potential with wildtype PDKZ1 for the Cterminus of each transport er (Fig. 6) . This may explain that activity of each trans porter in HEK293 W PDZK1E195K cells was higher, as in case of HEK293 W PDZK1 cells, than that in HEK293 cells. PDZ proteins may interact not only with trans porters, but also with other PDZ proteins and form a large protein complex consisting of several proteins. 1, 8, 9) Therefore, the E195K mutation may aect the forma tion of such large protein complexes, and this cannot be detected in experimental systems that investigate interaction between just two proteins. It should also be noted that interaction studies shown in Fig. 6 were performed just for the Cterminal domain of each trans porter. Therefore, such interaction may not precisely represent the one of fulllength transporters. Actually, stimulatory eect of PDZK1 on OCTN1mediated TEA uptake was still observed, when the last four amino acids of OCTN1 were deleted (Fig. 1B) , implying that functional modulation by PDZK1 may occur via other domains than the Cterminal region of OCTN1. This phenomenon was in contrast to that observed for OCTN2, stimulatory eect of PDZK1 being minimal for OCTN2D4 (Fig. 1D) . Therefore, in physiological conditions, E195K mutation may cause more obvious reduction in interaction potential between OCTN1 and PDZK1.
In conclusion, the present research suggested that variation of PDZK1 may aect subcellular localization and activity of several transporters, which interact with PDZK1, altering membrane transport of many types of substrate compounds. Further investigations in this adaptor protein are needed to understanding of its pharmacological roles.
